Related by context. All words. (Click for frequent words.) 72 Neurodex 66 bicifadine 66 pseudobulbar affect PBA 65 confirmatory Phase III 65 desvenlafaxine succinate 64 teriflunomide 64 tezampanel 64 dextromethorphan quinidine 63 KRN# 63 MoxDuo IR 63 alvimopan 63 FTY# 63 Dacogen injection 63 Nuedexta 63 MAP# 63 desvenlafaxine 63 febuxostat 62 Octreolin 62 Zenvia Phase III 62 Zenvia ™ 62 AeroLEF TM 62 TELINTRA 61 phase IIa clinical 61 Phase 2b trial 61 GSK# [001] 61 iloperidone 61 vorinostat 61 elotuzumab 61 SILENOR TM 61 mapatumumab 61 placebo controlled clinical 61 LEVADEX 61 pertuzumab 61 Corlux 61 diabetic neuropathic pain 61 NUEDEXTA 61 NGX# 60 laquinimod 60 APF# 60 lurasidone 60 paliperidone ER 60 telcagepant 60 Vilazodone 60 Marqibo 60 Zenvia TM 60 Azedra 60 eltrombopag 60 Phase 2a trial 60 SEROQUEL XR 60 canakinumab 60 dose cohorts 60 oxymorphone ER 60 picoplatin 60 Ophena TM 60 INCB# [001] 60 tasocitinib 60 MoxDuo 60 GAMMAGARD 60 Targretin 60 teduglutide 60 tolerability 60 JAK inhibitor 60 PEG SN# 60 subcutaneous formulation 60 Complete Response 60 efficacy tolerability 60 neratinib 60 Phase Ib study 59 EDEMA3 59 RAPAFLO 59 Vaprisol 59 asenapine 59 Cloretazine R VNP#M 59 dacetuzumab 59 rotigotine 59 RSD# 59 forodesine 59 BEMA Buprenorphine 59 Phase 2b clinical 59 dalbavancin 59 Tarceva TM 59 ponatinib 59 Androxal TM 59 ranolazine 59 Traficet EN 59 lintuzumab 59 FROVA 59 Levetiracetam 59 KNS # 59 ZOLINZA 59 Phase IIIb clinical 59 CorVue ™ 59 Mylotarg 59 tocilizumab 59 amrubicin 59 vilazodone 59 active comparator 59 NP2 Enkephalin 59 FOLOTYN 59 enzastaurin 59 ACTEMRA 59 Zerenex 59 ITAX 59 cangrelor 59 ularitide 59 TREANDA 59 Dyloject TM 59 MGCD# [001] 59 brivaracetam 59 lubiprostone 59 elagolix 59 PROMACTA 59 opioid induced bowel dysfunction 59 Amrubicin 59 Entereg 59 HuLuc# 59 Nebido 59 Fludara 59 PXD# 59 Trexima 59 methylnaltrexone 59 INVEGA SUSTENNA 59 Q#IR 59 Focalin XR 59 Onrigin 58 glatiramer acetate 58 Cladribine Tablets 58 LymphoStat B 58 bifeprunox 58 paliperidone palmitate 58 EXPAREL ™ 58 TELCYTA 58 Bicifadine 58 EOquin TM 58 rilonacept 58 PEGylated interferon beta 1a 58 Golimumab 58 telbivudine 58 LEP ETU 58 huC# DM4 58 phase IIb trial 58 INCB# [002] 58 DAVANAT 58 analgesic efficacy 58 CoFactor 58 ARCOXIA 58 YONDELIS 58 subcutaneously administered 58 tolerability profile 58 pomalidomide 58 T Pred 58 MoxDuo TM IR 58 Phase 1b trial 58 SEROQUEL 58 BEMA TM Fentanyl 58 Betaferon ® 58 THALOMID 58 Clolar 58 ZYBRESTAT 58 Panzem R NCD 58 Iloperidone 58 ruxolitinib 58 OZURDEX ® 58 Phenoptin 58 Rivaroxaban 58 arzoxifene 58 Laquinimod 58 AZILECT R 58 axitinib 58 relapsing remitting multiple sclerosis 58 tanespimycin 58 efficacy endpoints 58 Tyrima 58 NEBIDO 58 CIMZIA ™ 58 LY# [003] 58 ORENCIA ® 58 NVA# 58 orBec 58 Pirfenidone 58 oral ridaforolimus 58 oral rivaroxaban 58 ixabepilone 58 NATRECOR R 58 oral prodrug 58 RAPTIVA 58 bazedoxifene 58 Phase IIa clinical 58 tecarfarin 58 evaluating tivozanib 58 Zelrix 58 Jevtana 58 Teriflunomide 58 iclaprim 58 eszopiclone 58 dexanabinol 58 icatibant 58 REVLIMID lenalidomide 58 Natalizumab 58 Icatibant 58 phase IIb clinical 58 Perforomist ™ Inhalation Solution 58 temsirolimus 58 vidofludimus 58 MERLIN TIMI 57 BAY #-# 57 RoACTEMRA 57 ACAPODENE 57 secondary efficacy endpoints 57 vandetanib 57 chronic angina 57 Ranexa 57 ORENCIA R 57 PRT# 57 BCX# 57 Onrigin TM 57 INT# [002] 57 Durezol TM 57 MNTX 57 Arcalyst 57 Phase III confirmatory 57 PEG PAL 57 PD LID 57 rufinamide 57 phase IIa 57 MAA submission 57 alvespimycin 57 Frova 57 PRISTIQ 57 Phase Ib clinical 57 pralatrexate 57 TOLAMBA 57 OMS#HP 57 Ketotransdel TM 57 eculizumab 57 Prosaptide 57 Xyrem ® 57 lacosamide 57 OvaRex ® MAb 57 R#/MEM # 57 Onbrez Breezhaler 57 decitabine 57 iniparib 57 pramipexole 57 MACUGEN 57 CORDAPTIVE 57 nalbuphine ER 57 LAF# 57 Archexin 57 Aryplase 57 PREOS 57 TORISEL 57 FASLODEX 57 Ambrisentan 57 ACTEMRA TM 57 TBC# 57 ILLUMINATE 57 CANCIDAS 57 Avanir 57 DASISION 57 ecallantide 57 Phase IIb trials 57 Aloxi injection 57 Ixempra 57 rNAPc2 57 abatacept 57 lomitapide 57 schizophrenia CIAS 57 Ketotransdel 57 Inhalation Solution 57 ADX# 57 Clonicel 57 Telavancin 57 QAB# 57 docetaxel Taxotere ® 57 Vandetanib 57 Chemophase 57 REMINYL ® 57 Phase 2a 57 octreotide acetate 57 Phase 1b 57 TNF inhibitor 57 divalproex sodium 57 REVLIMID ® 57 ALGRX 57 vicriviroc 57 LibiGel Phase III 57 linaclotide 57 6R BH4 57 rasagiline tablets 57 oral methylnaltrexone 57 IRESSA 57 MGd 57 non metastatic osteosarcoma 57 TAXUS Element Stent System 57 HGS# 57 treprostinil 57 ACZ# 57 Stalevo 57 Relivar 57 plus dexamethasone 57 Serdaxin 57 Anturol 57 IL# PE#QQR 57 cobiprostone 57 Asentar 57 dirucotide 57 OMNARIS HFA 57 Dalbavancin 57 cabazitaxel 57 GRALISE 57 sNDA submission 57 acyclovir Lauriad R 57 CIMZIA TM certolizumab pegol 57 VAPRISOL 57 COPAXONE R 57 Surfaxin LS 57 aprepitant 57 sNDA 57 aflibercept 57 GLYX 57 talactoferrin 57 HuMax EGFr 57 atypical antipsychotic 57 painful diabetic neuropathy 57 Xinlay 57 TREDAPTIVE 57 Cimzia ® certolizumab pegol 57 ProSavin 57 ruboxistaurin 57 Torisel 57 SPIRIVA HandiHaler 57 Navelbine 56 dasatinib 56 Adlea 56 FOLPI 56 dose cohort 56 Aloxi 56 Extavia 56 infusional 5-FU/LV 56 tapentadol ER 56 tafamidis 56 noninfectious uveitis 56 Hyphanox 56 AzaSite Plus 56 efficacy endpoint 56 Cimzia TM 56 relapsed refractory multiple myeloma 56 Pivotal Phase III 56 natalizumab 56 ferumoxytol 56 reslizumab 56 Numax 56 ONSOLIS 56 Increlex ® 56 efficacy 56 vernakalant 56 interferon gamma 1b 56 sunitinib malate 56 Phase IIa trial 56 adalimumab 56 Sanctura XR 56 AZILECT ® 56 mipomersen 56 JANUVIA 56 silodosin 56 galiximab 56 VA# [002] 56 INVEGA ® 56 Dapagliflozin 56 liprotamase 56 LEVADEX ™ 56 Levadex 56 EOquin 56 ALVESCO 56 MAGE A3 ASCI 56 BENLYSTA 56 Voltaren Gel 56 NLX P# 56 Exalgo 56 palifosfamide 56 antiplatelet agent 56 SNT MC# 56 dosing regimens 56 Xcytrin 56 apremilast 56 AGGRASTAT R 56 ELADUR 56 safinamide 56 T DM1 56 GOUT 56 Microplasmin 56 efalizumab 56 Androxal 56 DepoDur TM 56 cediranib 56 celgosivir 56 NOXAFIL 56 briakinumab 56 LibiGel ® 56 Dyloject 56 palonosetron 56 Imprime PGG 56 prucalopride 56 clinical trials Multikine 56 Soliris TM eculizumab 56 certolizumab 56 interferon beta 1b 56 Fibrillex TM 56 Fampridine SR 56 sorafenib tablets 56 registrational 56 Xibrom 56 vinorelbine tartrate 56 APTIVUS 56 Frova ® 56 Evoltra 56 BRIM2 56 otelixizumab 56 pegylated interferons 56 Phase 2b study 56 XmAb# 56 TYKERB 56 beclomethasone dipropionate 56 rFIXFc 56 M6G 56 Pennsaid R 56 #D#C# 56 OMNARIS Nasal Spray 56 Keppra ® XR 56 PEG Interferon lambda 56 dimebon 56 ROCKET AF 56 Lacosamide 56 AEGR 56 SILENOR 56 Pemetrexed 56 eslicarbazepine acetate 56 olanzapine Zyprexa 56 ciclesonide 56 Plenaxis TM 56 Gralise 56 IMGN# 56 LEVAQUIN ® 56 ISIS # 56 Phase 2a clinical 56 TRISENOX 56 Spiriva HandiHaler 56 SCH # 56 HQK 56 carfilzomib 56 HuMax CD4 56 indiplon 56 ICA # 56 oral cladribine 56 cetrorelix 56 TG# [003] 56 Soriatane 56 Tolvaptan 56 maximally tolerated dose 56 danoprevir 56 multicenter placebo controlled 56 ISENTRESS 56 Cloretazine 56 Zemplar Capsules 56 Vernakalant 56 Phase 1b clinical 56 docetaxel Taxotere R 56 ramelteon 56 Velcade bortezomib 56 Ranolazine 56 SinuNase 56 etanercept 56 Emend 56 ganetespib 56 VPRIV 56 bivalirudin 56 FOLOTYN ® 56 eniluracil 56 BROVANA 56 edoxaban 56 riociguat 56 regorafenib 56 Bezielle 56 pharmacokinetic PK study 56 TYSABRI 56 fidaxomicin 56 romidepsin 56 generation purine nucleoside 56 ONGLYZA 56 docetaxel Taxotere 56 Aflibercept 56 ezogabine 56 tolevamer 56 CIMZIA TM 56 Durezol 56 vismodegib 56 BNC# 56 azacitidine 56 PDE4 inhibitor 56 tipranavir 56 Serada 56 Vimpat R 56 Platinol 56 SAPHRIS 56 Ozarelix 56 Genz # 56 Engerix B 56 Relovair 56 investigational monoclonal antibody 56 chlorambucil 56 Proxinium TM 56 Genasense ® oblimersen 56 DU #b 56 pharmacokinetic profile 56 relapsing multiple sclerosis 56 Indiplon 56 pivotal Phase III 56 FDA approvable letter 56 Carfilzomib 56 ambrisentan 55 ONGLYZA ™ 55 EFAPROXYN 55 NeuroSTAT ® 55 metaglidasen 55 Firazyr 55 rosuvastatin #mg 55 investigational atypical antipsychotic 55 Alocrest 55 evaluating REVLIMID 55 Rezonic 55 Orapred ODT 55 Aclasta 55 Proellex TM 55 belimumab 55 Azilect ® 55 dyskinesia PD LID 55 Sym# 55 velafermin 55 Safinamide 55 baminercept 55 Solzira 55 pharmacokinetic PK 55 AVONEX ® 55 Efficacy Results 55 Saforis 55 tasimelteon 55 gadobutrol 55 denufosol 55 CTAP# Capsules 55 oral deforolimus 55 glatiramer 55 Ceplene 55 goserelin 55 DexaSite 55 Rhucin ® 55 AP# [003] 55 serotonin norepinephrine reuptake inhibitor 55 Adalimumab 55 Raptiva ® 55 AIR CF1 55 Orathecin 55 placebo controlled Phase 55 mGluR5 NAM 55 ADVEXIN 55 ospemifene 55 TYZEKA 55 Treanda 55 Phase 1b dose escalation 55 BRAF inhibitor 55 Phase IIb clinical 55 atrasentan 55 AGILECT R 55 Acapodene 55 Pixantrone 55 PhosLo 55 RSD# oral 55 SEROQUEL R 55 Cellegesic 55 cannabinor 55 COPAXONE ® 55 Exelixis compounds 55 visilizumab 55 FDA Approvable Letter 55 ascending dose 55 EVIZON 55 TNF alpha inhibitor 55 Relistor 55 glufosfamide 55 rosuvastatin calcium 55 mometasone furoate 55 Cethrin 55 ocular formulation 55 Gemzar ® 55 OPAXIO 55 Zomig 55 Reclast Aclasta 55 Kuvan 55 CEQ# 55 lasofoxifene 55 Ceflatonin 55 TroVax 55 Plicera 55 orally inhaled migraine 55 pioglitazone HCl 55 Nexavar ® 55 Allovectin 7 ® 55 Actemra 55 QRxPharma 55 hemostatic efficacy 55 mycophenolate mofetil 55 CIP ISOTRETINOIN 55 Abilify aripiprazole 55 Dual Opioid 55 Azixa 55 LUNESTA 55 Panzem R 55 OncoVEX GM CSF 55 torezolid phosphate 55 alicaforsen enema 55 confirmatory Phase 3 55 TOCOSOL Paclitaxel 55 rhIGF-I/rhIGFBP-3 55 Doxil 55 REMICADE ® 55 LUMINATE 55 Anturol TM 55 Junovan 55 Bifeprunox 55 figitumumab 55 Gabapentin GR 55 dose escalation clinical 55 pirfenidone 55 L MTP PE 55 darusentan 55 HGS ETR1 55 NUVIGIL 55 Amplimexon 55 CIP TRAMADOL ER 55 rivaroxaban 55 Targretin capsules 55 Triolex 55 Tezampanel 55 Arimoclomol 55 PEGINTRON TM 55 motesanib 55 ARIKACE 55 AGGRASTAT ® 55 Taxotere ® 55 CLARITY study 55 adalimumab Humira 55 pharmacokinetics PK 55 pharmacodynamic PD 55 Dasatinib 55 SUPPRELIN R LA 55 ocrelizumab 55 CAELYX 55 muraglitazar 55 MOZOBIL 55 belinostat 55 fondaparinux 55 davunetide 55 capsule formulation 55 intravenous acetaminophen 55 daclizumab 55 sorafenib Nexavar 55 Elagolix 55 opioid induced constipation 55 ancrod 55 oxcarbazepine 55 Bepreve 55 lucinactant 55 posaconazole 55 severe hypercholesterolemia 55 exenatide 55 Rebif ® 55 Celebrex celecoxib 55 tolerability profiles 55 ofatumumab 55 AEG# 55 tamibarotene 55 deforolimus 55 PLK1 SNALP 55 TPI ASM8 55 lesinurad 55 Vfend 55 Perforomist TM Inhalation Solution 55 Oral NKTR 55 fluvastatin 55 placebo controlled clinical trials 55 valopicitabine 55 budesonide 55 viral kinetics 55 BLA filing 55 sapacitabine 55 Excellarate 55 REVLIMID R 55 tezampanel NGX# 55 HP Acthar Gel repository 55 indacaterol 55 Trobalt 55 Mipomersen 55 Milnacipran 55 AeroLEF 55 ozarelix 55 CR# vcMMAE 55 Hsp# Inhibitor 55 bendamustine 55 Vidaza azacitidine 55 MIRCERA 55 Phase 1a clinical 55 Sandostatin LAR 55 latanoprost 55 Evoltra R 55 MBP# [001] 55 adipiplon 55 limiting toxicity DLT 55 placebo controlled trials 55 phase Ib 55 SYMBICORT 55 alfimeprase 55 oral FTY# 55 VELCADE melphalan 55 Benlysta belimumab 55 KAPIDEX 55 MEND CABG II 55 tesmilifene 55 RG# [001] 55 ARIKACE ™ 55 USL# 55 nab paclitaxel 55 refractory Hodgkin lymphoma 55 XGEVA 55 fingolimod 55 ALVESCO R 55 Neurodex TM 55 Capesaris 55 tolvaptan 55 eprotirome 55 Valortim 55 PRECiSE 55 CERVARIX 55 calcineurin inhibitors 55 Zenpep 55 Cinryze 55 tigecycline 55 zolmitriptan 55 leukemia AML 55 pegloticase 55 Onsolis 55 Phase IIB 55 HZT 55 registrational trial 55 Acetavance 55 systemic immunosuppressive drugs 55 Genasense R oblimersen 55 Rasagiline 55 metformin HCl 55 indiplon capsules 55 ALKS 55 cutaneous T cell 55 degarelix 55 Etanercept 55 vinorelbine 55 ustekinumab 55 peginesatide 55 Bronchitol 55 Vimpat 55 BYDUREON 55 Phase IIIb 55 NasalFent 55 oral diclofenac 55 tolerated dose MTD 55 placebo controlled Phase III 55 ARIXTRA 55 cystinosis patients 55 viral kinetic 55 PREZISTA r 55 Synvisc One 55 Omnaris 55 Ventavis 55 Phase Ib 55 Clolar ® 55 QNEXA 55 mertansine 55 pharmacokinetic equivalence 54 GALNS 54 Angiomax 54 pregabalin 54 EURIDIS 54 vosaroxin 54 angiographic outcomes 54 Genasense 54 TYGACIL 54 aclidinium bromide 54 Pimavanserin 54 IIa trial 54 Phase Ib II 54 rilpivirine 54 Rasilez Tekturna 54 proton pump inhibitor PPI 54 ZEGERID Capsules 54 LE DT 54 ataluren 54 BrachySil 54 adenosine injection 54 refractory AML 54 HER2 positive metastatic breast 54 ADHF 54 sirolimus eluting stent 54 renal toxicity 54 Intermezzo R 54 roflumilast 54 CDP# 54 Avastin bevacizumab 54 rALLy trial 54 custirsen 54 HspE7 54 tenofovir emtricitabine 54 Campath alemtuzumab 54 Horizant 54 novel histone deacetylase 54 levetiracetam 54 romiplostim 54 atherothrombotic events 54 Aloxi R 54 Alzhemed TM 54 Albuferon 54 ridaforolimus 54 Phase IIb clinical trials 54 PEG INTRON 54 antidepressant efficacy 54 Lubiprostone 54 Pegasys ® 54 phase IIb 54 dosage regimens 54 Altastaph 54 ONTAK 54 Entereg R 54 bosutinib 54 rolofylline 54 AMRIX 54 Betaferon R 54 abiraterone acetate 54 placebo controlled studies 54 histone deacetylase HDAC inhibitor 54 Combidex 54 SNRI 54 incyclinide 54 Promacta 54 albinterferon alfa 2b 54 nonclinical studies 54 Ocrelizumab 54 trospium 54 LIALDA 54 MabCampath 54 Cethromycin 54 Daytrana ® 54 aplindore 54 PASI scores 54 dronedarone 54 Evoltra ® 54 Folotyn 54 DEXILANT 54 Keppra ® 54 rosuvastatin 54 Vicinium TM 54 ISTODAX 54 motavizumab 54 Zalbin 54 ibandronate 54 ARCALYST 54 pharmacodynamics PD 54 oxaliplatin Eloxatin 54 Tasimelteon 54 Alfimeprase 54 Symbyax 54 budesonide foam 54 Phase IIb 54 OHR/AVR# 54 cladribine tablets 54 ADVANCE PD 54 levosimendan 54 Ticagrelor 54 Romiplostim 54 Kynapid 54 timolol 54 mifamurtide 54 ULORIC 54 IPLEX 54 postoperative ileus POI 54 Cimzia 54 methylnaltrexone bromide 54 plasma kallikrein inhibitor 54 BEMA TM LA 54 relapsed myeloma 54 primary hypercholesterolemia 54 sipuleucel T 54 IMiDs 54 Tanespimycin 54 non constipation irritable 54 octreotide 54 prokinetic agent 54 Emselex 54 fenofibric acid 54 Mycamine 54 VIDAZA 54 aripiprazole 54 AIR CF2 54 R# #mg BID 54 RE SURGE 54 mg dose 54 peg interferon 54 dose limiting toxicities 54 faropenem 54 statistically significant superiority 54 ALVESCO HFA 54 zonisamide SR 54 phase 2a 54 satraplatin 54 refractory gout 54 CRMD# 54 NEVO ™ 54 PKC# 54 octreotide implant 54 Tamibarotene 54 FIRAZYR 54 pixantrone 54 rindopepimut 54 ADAGIO study 54 O PPDS 54 Ereska 54 OXi# 54 low dose cytarabine 54 zileuton CR 54 obatoclax 54 Rotigotine 54 REYATAZ R 54 zafirlukast 54 Intermezzo ® 54 Onalta 54 Abatacept 54 gepirone ER 54 antiepileptic drug 54 PHX# 54 Tygacil 54 lumiliximab 54 proprietary transdermal patch 54 HuMax CD# 54 ketoprofen patch 54 Gattex 54 Resolute DES 54 voreloxin 54 veltuzumab 54 avanafil 54 iSONEP 54 Glybera 54 Duromist ™ 54 RGB # 54 Sprycel dasatinib 54 randomized multicenter Phase III 54 #mg BID [001] 54 Topotecan 54 lapatinib Tykerb 54 ABSORB trial 54 HCD# [002] 54 ToGA 54 CORT # 54 anticancer compound 54 xanthine oxidase inhibitor 54 trabectedin 54 GATTEX 54 TriRima 54 urate lowering 54 favorable tolerability 54 rHuPH# 54 Rezular 54 severe gastroparesis 54 EMBEDA ™ 54 Luveniq 54 atacicept 54 LEXIVA r 54 novel oral anticoagulant 54 investigational drug 54 diarrhea predominant irritable 54 Alvesco R 54 alfa 2a 54 alogliptin 54 AZILECT 54 IPX# 54 cardiac toxicity 54 HyQ 54 Darusentan 54 Luvox CR 54 noninferiority 54 zalutumumab 54 fosbretabulin 54 Krystexxa 54 Phase IIb trial